Literature DB >> 24925540

Pneumococcal vaccine failure: can it be a primary immunodeficiency?

Rita Moinho1, Ana Brett1, Gisela Ferreira2, Sónia Lemos1.   

Abstract

Vaccine failure is a rare condition and the need to investigate a primary immunodeficiency is controversial. We present the case of a 4-year-old boy, with complete antipneumococcal vaccination, who had necrotising pneumonia with pleural effusion and severe pancytopaenia with need for transfusion. A vaccine-serotype Streptococcus pneumoniae was isolated in the blood culture. On follow-up, detailed medical history, laboratory and genetic investigation led to the diagnosis of X linked dyskeratosis congenita. Dyskeratosis congenita is an inherited disorder that causes shortening or dysfunction of telomeres, affecting mainly rapidly dividing cells (particularly in the skin and haematopoietic system). It leads to bone marrow failure, combined immunodeficiency and predisposition to cancer. The confirmation of this diagnosis allows genetic counselling and medical monitoring of these patients, in order to detect early complications such as bone marrow aplasia or malignancies. 2014 BMJ Publishing Group Ltd.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24925540      PMCID: PMC4069748          DOI: 10.1136/bcr-2014-204714

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  24 in total

1.  General recommendations on immunization. Recommendations of the Advisory Committee on Immunization Practices (ACIP) and the American Academy of Family Physicians (AAFP).

Authors:  William L Atkinson; Larry K Pickering; Benjamin Schwartz; Bruce G Weniger; John K Iskander; John C Watson
Journal:  MMWR Recomm Rep       Date:  2002-02-08

Review 2.  Dyskeratosis congenita: a combined immunodeficiency with broad clinical spectrum--a single-center pediatric experience.

Authors:  S Jyonouchi; L Forbes; E Ruchelli; K E Sullivan
Journal:  Pediatr Allergy Immunol       Date:  2011-02-01       Impact factor: 6.377

3.  Safety and immunogenicity of a 13-valent pneumococcal conjugate vaccine.

Authors:  Kristina A Bryant; Stan L Block; Sherryl A Baker; William C Gruber; Daniel A Scott
Journal:  Pediatrics       Date:  2010-05       Impact factor: 7.124

Review 4.  Dyskeratosis congenita as a disorder of telomere maintenance.

Authors:  Nya D Nelson; Alison A Bertuch
Journal:  Mutat Res       Date:  2011-07-02       Impact factor: 2.433

5.  Invasive pneumococcal infections among vaccinated children in the United States.

Authors:  Sarah Y Park; Chris A Van Beneden; Tamara Pilishvili; Michael Martin; Richard R Facklam; Cynthia G Whitney
Journal:  J Pediatr       Date:  2009-12-03       Impact factor: 4.406

Review 6.  Advances in the understanding of dyskeratosis congenita.

Authors:  Amanda J Walne; Inderjeet Dokal
Journal:  Br J Haematol       Date:  2009-02-04       Impact factor: 6.998

7.  Dyskeratosis congenita: the first NIH clinical research workshop.

Authors:  Sharon A Savage; Inderjeet Dokal; Mary Armanios; Geraldine Aubert; Edward W Cowen; Demetrio L Domingo; Neelam Giri; Mark H Greene; Paul J Orchard; Jakub Tolar; Ekaterini Tsilou; Carter Van Waes; Judy M Y Wong; Neal S Young; Blanche P Alter
Journal:  Pediatr Blood Cancer       Date:  2009-09       Impact factor: 3.167

8.  Telomere phenotypes in females with heterozygous mutations in the dyskeratosis congenita 1 (DKC1) gene.

Authors:  Jonathan K Alder; Erin M Parry; Srinivasan Yegnasubramanian; Christa L Wagner; Lawrence M Lieblich; Robert Auerbach; Arleen D Auerbach; Sarah J Wheelan; Mary Armanios
Journal:  Hum Mutat       Date:  2013-09-11       Impact factor: 4.878

9.  DNA damage responses and oxidative stress in dyskeratosis congenita.

Authors:  Larisa Pereboeva; Erik Westin; Toral Patel; Ian Flaniken; Lawrence Lamb; Aloysius Klingelhutz; Frederick Goldman
Journal:  PLoS One       Date:  2013-10-04       Impact factor: 3.240

10.  Dyskeratosis congenita: a report of two cases.

Authors:  Anila Karunakaran; Rathy Ravindran; Mohammed Arshad; M Kodanda Ram; M K Shruthi Laxmi
Journal:  Case Rep Dent       Date:  2013-08-06
View more
  1 in total

1.  Other age groups than children need to be considered as carriers of Streptococcal pneumoniae serotypes.

Authors:  Hans-Christian Slotved
Journal:  Hum Vaccin Immunother       Date:  2016-06-20       Impact factor: 3.452

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.